| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 949 | 2018 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 750 | 2018 |
| Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees K Dolan, AL Wirtz, B Moazen, M Ndeffo-Mbah, A Galvani, SA Kinner, ... The Lancet 388 (10049), 1089-1102, 2016 | 705 | 2016 |
| Four‐year follow‐up of imprisoned male heroin users and methadone treatment: mortality, re‐incarceration and hepatitis C infection KA Dolan, J Shearer, B White, J Zhou, J Kaldor, AD Wodak Addiction 100 (6), 820-828, 2005 | 310 | 2005 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 283 | 2018 |
| The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia FL Altice, L Azbel, J Stone, E Brooks-Pollock, P Smyrnov, S Dvoriak, ... The Lancet 388 (10050), 1228-1248, 2016 | 282 | 2016 |
| HIV in prison in low-income and middle-income countries. K Dolan, B Kite, E Black, C Aceijas, GV Stimson The Lancet Infectious Diseases 7 (1), 32, 2007 | 281 | 2007 |
| A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system KA Dolan, J Shearer, M MacDonald, RP Mattick, W Hall, AD Wodak Drug and alcohol dependence 72 (1), 59-65, 2003 | 270 | 2003 |
| Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia K Dolan, Jo Kimber, Craig Fry, David McDonald, John Fitzgerald, Franz Trautmann Drug and alcohol review 19 (3), 337-346, 2000 | 251 | 2000 |
| Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001 MG Law, GJ Dore, N Bath, S Thompson, N Crofts, K Dolan, W Giles, ... International journal of epidemiology 32 (5), 717-724, 2003 | 234 | 2003 |
| Prison‐based syringe exchange programmes: a review of international research and development K Dolan, S Rutter, AD Wodak Addiction 98 (2), 153-158, 2003 | 225 | 2003 |
| Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners A Kamarulzaman, SE Reid, A Schwitters, L Wiessing, N El-Bassel, ... The Lancet 388 (10049), 1115-1126, 2016 | 221 | 2016 |
| An overview of the use of urine, hair, sweat and saliva to detect drug use K Dolan, D Rouen, J Kimber Drug and Alcohol Review 23 (2), 213-217, 2004 | 210 | 2004 |
| Hepatitis B and C in New South Wales prisons: prevalence and risk factors TG Butler, KA Dolan, MJ Ferson, LM McGuinness, PR Brown, ... Medical Journal of Australia 166 (3), 127-130, 1997 | 191 | 1997 |
| Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort JJ Post, Y Pan, AJ Freeman, CE Harvey, PA White, P Palladinetti, ... Journal of Infectious Diseases 189 (10), 1846-1855, 2004 | 187 | 2004 |
| Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997 MA MacDonald, JM Kaldor, AD Wodak, KA Dolan, I van Beek, ... Medical Journal of Australia 172 (2), 57-61, 2000 | 172 | 2000 |
| Modelling the hepatitis C virus epidemic in Australia K Razali, HH Thein, J Bell, M Cooper-Stanbury, K Dolan, G Dore, ... Drug and alcohol Dependence 91 (2), 228-235, 2007 | 171 | 2007 |
| Drug consumption facilities: an update since 2000 J Kimber, K Dolan, I Van Beek, D Hedrich, H Zurhold Drug and alcohol review 22 (2), 227-233, 2003 | 166 | 2003 |
| Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland. MC Donoghoe, GV Stimson, K Dolan, L Alldritt AIDS (London, England) 3 (5), 267, 1989 | 147 | 1989 |
| People who inject drugs in prison: HIV prevalence, transmission and prevention K Dolan, B Moazen, A Noori, S Rahimzadeh, F Farzadfar, F Hariga International Journal of Drug Policy 26, S12-S15, 2015 | 135 | 2015 |
Wayne HallProfessor, University of QueenslandVerified email at uq.edu.au
